A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema

• Status: Completed
• Trial end date: 2013-04-15
• Target enrollment: 0
• Participant gender: All

Summary

This retrospective chart review study will describe the history of patients with retinal disease with macular edema to whom OZURDEX® (dexamethasone intravitreal implant) is administered, and assess treatment patterns and visual outcomes. OZURDEX® was previously administered according to general clinical practice.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: BB 1101; Dexamethasone; Dexamethasone 21-phosphate; Dexamethasone acetate

Criteria

Inclusion Criteria:

• Retinal disease involving macular edema

• Received at least one OZURDEX® injection

Exclusion Criteria:

• None